Skip to main content
PMC home page
Saudi Journal of Biological Sciences logoLink to Saudi Journal of Biological Sciences
. 2021 Dec 11;29(3):1380–1385. doi: 10.1016/j.sjbs.2021.12.012

Pachypodol attenuates Perfluorooctane sulphonate-induced testicular damage by reducing oxidative stress

Muhammad Umar Ijaz a, Ayesha Rauf a, Shama Mustafa a, Hussain Ahmed b, Asma Ashraf c,⁎, Khalid Al-Ghanim d, Satyanarayana Swamy Mruthinti e, S Mahboob d,⁎⁎
PMCID: PMC8913419  PMID: 35280584

Abstract

Perfluorooctane sulfonate (PFOS) is an endocrine disruptor chemical (EDC) with potentially adverse effects on the male reproductive system. Pachypodol (5,4′-dihydroxy-3,7,3′-trimethoxyflavone) is a promising flavonoid isolated from Pogostemon cablin (Blanco) Benth that shows a broad range of pharmacological properties. However, the potential curative effects of pachypodol on testicular toxicity are not available until now. Therefore, this research was proposed to examine the efficiency of pachypodol against PFOS-induced testicular toxicity in adult male rats. The experiments were conducted on Sprague-Dawley rats (n = 48), which were equally distributed into four groups: control, PFOS (20 mg/kg), PFOS + Pachypodol (20 mg/kg + 10 mg/kg respectively), and Pachypodol (10 mg/kg). After 56 days of treatment, testes were excised by slaughtering rats, weighed, and stored till further analysis. The estimated parameters include biochemical markers, spermatogenic indices, hormonal and histopathological profiles. PFOS exposure disturbed the biochemical profile by altering the antioxidant/oxidant balance. For instance, it decreased the activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GSR) while increasing the concentration of reactive oxygen species (ROS) and level of thiobarbituric acid reactive substances (TBARS). PFOS intoxication also led to a notable decline in viability, motility, epididymal sperm count, and the number of HOS coiled-tail sperms, whereas the higher level of abnormality in the head, mid-piece, and tail of sperms were observed. Besides, it lowered luteinizing hormone (LH), follicle-stimulating hormone (FSH), and plasma testosterone. In addition, PFOS exposure led to histopathological damages in testicles. However, pachypodol treatment potently alleviated all the illustrated impairments in testes. Conclusively, our results demonstrate the promising free-radical scavenging activity of pachypodol, a novel phytochemical, against the PFOS-instigated testicular dysfunctions.

Keywords: Perfluorooctane sulfonate, Pachypodol, Testicular toxicity, Reactive oxygen species, Oxidative stress, Antioxidant

1. Introduction

Per-and polyfluoroalkyl substances (PFASs) are synthetic chemicals that show adverse effects on the ecosystem and human health (Zhang et al., 2020). According to some global statistics, over 4700 PFASs have been identified (OECD, 2018). Among these PFASs, perfluorooctane sulfonate (PFOS) is a widely used surfactant due to its excellent thermal stability and hydrophobic properties, which adversely affect humans and wildlife (Chen et al., 2021). Environmental sources of PFOS exposure include commercial and industrial products, such as cookware, furniture, household cleaners, clothing, and firefighting foam (Sunderland et al., 2019). Furthermore, drinking water and contaminated foods are the chief sources of PFOS exposure to humans (Alam et al., 2021). Primary routes of PFOS exposure to the human body are ingestion, inhalation, and dermal contact (Poothong et al., 2020). Inside the body, PFOS bind to serum proteins and renal transporter proteins that restrict its discharge in urine due to its reabsorption in the kidneys (Worley and Fisher, 2015). The estimated half-life of PFOS in the human body is 3.4 years (Li et al., 2018).

It is evident from multiple kinds of researches, PFOS exposure in model animals potently influences various biological processes, i.e., neurotoxicity (Negri et al., 2017), endocrine disruption (Coperchini et al., 2017), blood-testis barrier impairment (Wan et al., 2014), and developmental toxicity in the reproductive system (Xu et al., 2017). Furthermore, PFOS prevents sex maturation by acting as an antiandrogen (Di Nisio et al., 2019). The mediator of PFOS-induced reproductive toxicity is oxidative stress (OS) (Oseguera-López et al., 2020). Previous literature shows that OS deteriorates spermatozoa, leading to male infertility (Agarwal and Sengupta, 2020). It arises when the overproduction of ROS disrupts the oxidant/antioxidant balance (Yilmaz et al. (2017)). As feedback, this redox imbalance leads to lipid peroxidation (LP) in the testicle and sperm cells as testes hold large amounts of polyunsaturated fatty acids (PUFA) (Bisht et al., 2017). Hence, OS-induced LP can be deleterious to steroidogenesis and spermatogenesis in testicular tissues (Ijaz et al., 2021a). PFOS exposure in humans can cause reduced sperm motility (Song et al., 2018), epididymal sperm count (Gao et al., 2017), and deterioration of semen quality and quantity (Toft et al., 2012). Thus, after analyzing the various sources of PFOS exposure and their adverse effects on human health, particularly on testes, research on remedies against PFOS-instigated toxicities is desired.

Flavonoids are a polyphenolic family of plants' bioactive secondary metabolites (Nabavi et al., 2020). The chief flavonoid reservoirs are vegetables and fruits (Liu et al., 2018). Among these plant polyphenolic families, pachypodol (4′,5-dihydroxy-3,3′,7-trimethoxyflavone) is a natural dietary flavonoid, which is isolated from Pogostemon cablin (Blanco) Benth with reported antioxidant (Kim et al., 2019), anti-apoptotic (Zhang et al., 2021), antimicrobial (Krithika et al., 2021), and cytoprotective (Kim et al., 2019) properties. Despite these potential curative effects of pachypodol, its ameliorative potential on testicular toxicity is not available until now. Therefore, current research ascertained the alleviated potential of pachypodol for PFOS-instigated testicular toxicities. Hence, to accomplish this aim, PFOS and pachypodol were orally cotreated to adult male Sprague-Dawley rats for 56 days, after which OS and resultant pathological alterations, such as sperm count, motility, morphology, hormone levels, and histopathology of testicular tissues were analyzed.

2. Materials and methods

2.1. Chemicals

PFOS and Pachypodol were purchased from Sigma-Aldrich, Germany.

2.2. Animals

Adult male Sprague-Dawley rats (180 ± 20 g) were obtained from the animal house of the University of Agriculture Faisalabad (UAF), which were kept in steel cages at standard 12 h light/dark cycle, temperature (22–25 °C), and humidity (45 ± 5%). Food and Tap water (H2O) were given ad libitum. This study was conducted in compliance with the guidelines for the supervision and handling of animals stated by the institutional ethics committee, University of Agriculture, Faisalabad.

2.3. Experimental design

Rats (n = 48) were randomly divided into four groups (12 rats/group): Control, PFOS, PFOS + Pachypodol, and Pachypodol alone. 20 mg/kg dose of PFOS and 10 mg/kg dose of Pachypodol were used in this experiment, and all the doses were given orally. Rats were handled according to the European Union of animal care and experimentation (CEE Council 86/609) guidelines. At the end of 56 days of treatment, rats were killed by decapitation, and testes were excised, weighed, and stored at −80 °C till further analysis.

2.4. Biochemical markers

The activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GSR) were quantified by following the previous techniques (Chance and Maehly, 1955, Kakkar et al., 1984, Lawrence and Burk, 1976); Carlberg and Mannervik, 1975), whereas the concentration of reactive oxygen species (ROS), as well as thiobarbituric acid reactive substances (TBARS) level, was measured according to the protocols of Hayashi et al., 2007, Iqbal et al., 1996 respectively.

2.5. Semen analysis

Caudal piece of epididymis was isolated to take the semen samples. Initially, the epididymal part was minced in 5 mL of physiological-saline and then heated for a half-hour at 37 °C to let the sperms abscond from the epididymis. Sperm motility was recorded with the help of a phase-contrast microscope at 400X (Kenjale et al., 2008). Sperm viability was estimated by eosin and nigrosin staining, followed by microscopic evaluation. Moreover, a hemocytometer was employed to count epididymal sperm (Yokoi et al., 2003). Furthermore, morphological anomalies of head, tail, and mid-piece of sperm were ascertained by the process of Cao et al. (2017).

2.6. Hypo-osmotic swelling (HOS) test

The HOS test was employed to measure the morphological sperm plasma membrane integrity. In the first step, 20 μL of semen sample was placed in 180 μL of fructose solution at 80 mOsm/L osmotic pressure for about 20 min. After subsequent incubation and mixing, the sperm were stained with eosin and nigrosin. Lastly, microscopically (400X), 200 spermatozoa with swollen and non-swollen tails were analyzed (Correa and Zavos, 1994).

2.7. Hormonal assay

Specific enzyme-linked immunosorbent assay (ELISA) kits were employed to quantify the serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and plasma testosterone.

2.8. Histopathology

Tissue samples for histopathological analysis were obtained from the left testis of the rats. For light microscopy, samples were fixed for about 48 h in a 10% formaldehyde solution, then immediately dehydrated in rising grades of alcohol and encased in paraffin wax. Later these paraffin-inserted blocks (5 μm) were cut and stained with hematoxylin-eosin (H & E). Lastly, Leica LB microscope and Image-J2X software were used respectively to take or analyze the images of the sample.

2.9. Statistical analysis

Data are shown as means ± SEM. The normality of data was first tested using Levene’s test. A one-way analysis made comparisons of the differences of variance (ANOVA) followed by Fisher's LSD for multiple comparisons or nonparametric Kruskal-Wallis as appropriate. Statistical significance was taken at P < 0.05. All analyses were performed using Minitab software.

3. Results

3.1. Effect of pachypodol on biochemical markers

Table 1 represents the mean values of biochemical markers. PFOS exposure substantially (p < 0.05) reduced the activity of enzymatic antioxidants such as CAT, SOD, GPx, or GSR, while augmenting the ROS and TBARS level concentration in PFOS-treated rats in comparison to the control rats. Co-administration of pachypodol with PFOS provoked substantial (p < 0.05) elevation in CAT, SOD, GPx, and GSR activities along with a significant (p < 0.05) decrease in the concentration of ROS and TBARS levels in contrast to the PFOS-exposed rats. Furthermore, the pachypodol alone treatment group did not exhibit any significant (p < 0.05) variations in the status of the biochemical assay as compared with the control group.

Table 1.

Mean ± SEM of biochemical markers in the testicles of control, PFOS-treated, cotreated, and pachypodol groups.

Parameters Groups
Control PFOS PFOS + Pachypodol Pachypodol
CAT (U/mg protein) 9.17 ± 0.23a 5.38 ± 0.15b 8.28 ± 0.11a 9.24 ± 0.25a
SOD (U/mg protein) 6.55 ± 0.35a 3.22 ± 0.06b 5.88 ± 0.22c 6.58 ± 0.41a
GPx (U/mg protein)) 18.32 ± 0.59a 9.17 ± 0.17b 14.72 ± 0.41c 18.55 ± 0.69a
GSR (nm NADPH oxidized/min/mg tissue 5.07 ± 0.15a 1.41 ± 0.19b 3.84 ± 0.100c 5.13 ± 0.17a
ROS (U/mg tissue) 1.06 ± 0.16a 7.11 ± 0.27b 2.02 ± 0.100c 1.03 ± 0.13a
TBARS (nM/min/mg tissue) 12.25 ± 1.15a 28.43 ± 0.74b 16.33 ± 0.66c 12.14 ± 1.12a
Open in a new tab

Values having various superscripts are considerably (p < 0.05) distinct from other groups.

3.2. Effect of pachypodol on semen analysis

Table 2 shows the semen indices. PFOS exposure substantially (p < 0.05) reduced the sperm viability, motility, epididymal sperm, and HOS coil-tailed sperm count while increasing the morphological sperm anomalies (head, mid-piece, and tail) in contrast to the control group. However, pachypodol-supplementation substantially (p < 0.05) inverted all these sperm indices to a normal state in the co-treated group compared to the PFOS-induced group. Nevertheless, only pachypodol-administered rats exhibited a regular semen profile as in the control rats.

Table 2.

Mean ± SEM of semen assay in control, PFOS-treated, cotreated, and pachypodol groups.

Parameters Groups
Control PFOS PFOS + Pachypodol Pachypodol
Motility (%) 88.88 ± 3.47a 35.70 ± 1.11b 71.58 ± 1.98c 89.97 ± 3.85a
Dead Sperms (%) 7.80 ± 1.35a 86.56 ± 1.79b 12.22 ± 4.54c 7.41 ± 1.29a
Head Abnormality (U/mg protein) 4.85 ± 0.50a 19.45 ± 1.25b 8.59 ± 0.73c 4.64 ± 0.44a
Mid Sperm Abnormality (%) 0.70 ± 0.09a 8.91 ± 0.55b 1.65 ± 0.13c 0.67 ± 0.15a
Tail Abnormality (%) 1.51 ± 0.08a 15.48 ± 0.63b 3.52 ± 0.22c 1.45 ± 0.12a
Hypo-osmotic swelled sperm count (HOS) (%) 86.17 ± 1.91a 25.57 ± 1.85b 65.46 ± 1.67c 86.62 ± 2.08a
Epididymal Sperm Count (million/mL) 29.20 ± 1.31a 11.69 ± 0.78b 24.68 ± 0.65c 29.25 ± 1.77a
Open in a new tab

Values having various superscripts are considerably (p < 0.05) distinct from other groups.

3.3. Effect of pachypodol on hormonal assay

Table 3 demonstrates the mean values of the hormonal assay. PFOS intoxication substantially (p < 0.05) reduced the LH, FSH, and plasma testosterone levels in the PFOS group compared to the control group. However, cotreatment of pachypodol with PFOS significantly (p < 0.05) restored the above-stated hormonal levels compared to the PFOS group. Besides, the pachypodol-treated group displayed the average level of the hormonal assay as shown in the control group.

Table 3.

Mean ± SEM of the hormonal assay in control, PFOS-treated, cotreated, and pachypodol groups.

Parameters Groups
Control PFOS PFOS + Pachypodol Pachypodol
LH (ng/ml) 2.35 ± 0.11a 0.82 ± 0.13b 2.05 ± 0.07a 2.39 ± 0.13a
FSH (ng/ml) 4.06 ± 0.12a 1.29 ± 0.10b 3.72 ± 0.19a 4.11 ± 0.13a
Plasma testosterone (ng/ml) 4.61 ± 0.09a 2.10 ± 0.08b 3.73 ± 0.07a 4.68 ± 0.11a
Open in a new tab

Values having various superscripts are considerably (p < 0.05) distinct from other groups.

3.4. Effect of pachypodol on histopathology

The histopathological alterations following the PFOS and pachypodol administration are shown in Table 4 and Fig. 1. PFOS induction substantially (p < 0.05) lessened the diameter, epithelial height of seminiferous tubules, and the thickness of tunica albuginea. Furthermore, it scaled up the luminal diameter of tubules. PFOS-intoxication also significantly (p < 0.05) reduced germ cell count such as spermatogonia, spermatids, primary and secondary spermatocytes compared with the control group. Nonetheless, pachypodol supplementation in the cotreated group substantially (p < 0.05) recovered all these structural anomalies and the number of germ cells in testicles compared to the PFOS-induced group. However, there were no significant (p < 0.05) differences among the mean values of pachypodol-treated and the control groups.

Table 4.

Mean ± SEM of histopathology of rat testicles in control, PFOS-treated, cotreated, and pachypodol groups.

Parameters units Groups
Control PFOS PFOS + Pachypodol Pachypodol
Interstitial Spaces (µm) 9.84 ± 0.41a 36.72 ± 3.35b 15.98 ± 0.75c 9.54 ± 0.35a
Tunica Albuginea (µm) 68.76 ± 2.07a 15.26 ± 0.73b 53.55 ± 1.34c 70.53 ± 2.85a
Seminiferous Tubules (µm) 356.26 ± 7.01a 110.63 ± 9.78b 306.15 ± 4.45c 348.73 ± 7.69a
Seminiferous Tubule Epithelial Height (µm) 94.08 ± 3.14a 31.71 ± 1.60b 74.56 ± 2.28c 93.00 ± 4.44a
Tubular Lumen (µm) 24.79 ± 1.21a 84.18 ± 1.63b 37.8 ± 2.00a 25.06 ± 1.66a
Spermatogonia 61.43 ± 1.61a 19.12 ± 1.41b 52.96 ± 1.64a 62.55 ± 4.48a
Spermatids 48.99 ± 2.00a 22.73 ± 0.99b 44.36 ± 0.83c 49.54 ± 2.05a
Primary Spermatocytes 45.09 ± 1.06a 18.29 ± 1.00b 38.21 ± 0.87c 45.40 ± 1.38a
Secondary Spermatocytes 34.01 ± 0.75a 11.74 ± 0.60b 28.65 ± 0.59c 34.31 ± 0.82a
Open in a new tab

Values having various superscripts are considerably (p < 0.05) distinct from other groups.

Fig. 1.

Fig. 1

Open in a new tab

(A) Control group demonstrating thick germinal epithelium including different stages of germ cells and the slender luminal area carrying spermatozoa; (B) PFOS group displaying sloughing of the epithelial layer, vacant lumen, and degeneration of IS; (C) PFOS + Pachypodol group displaying reduced sloughing of germinal epithelium, TL filled with ST and degenerated IS; (D) Pachypodol group representing compact ST with less IS. IS Interstitial spaces; TL: Tubular lumen; EH: Seminiferous Epithelial height; ST: Seminiferous tubules; TA: Tunica albuginea; SG: Spermatogonia; ST: Spermatids; PS: Primary spermatocytes; SS: Secondary spermatocytes.

4. Discussion

Due to wide occurrence, resistance to degradation, or bioaccumulation in the environment, PFOS is considered one of the emerging persistent organic pollutants (POPs) and exerted potentially deleterious impacts on the ecosystem and humans, including their male reproductive system (Tescari and Nisio, 2017). Administration of this drug causes excessive ROS generation, which results in an imbalance of antioxidant and pro-oxidant enzymes (Li et al., 2017). Furthermore, the over-generation of ROS is one of the main reasons behind the deteriorated semen quality (Ijaz et al., 2020). Thus, the use of antioxidants potently alleviates the PFOS-instigated oxidative damage in testicular tissues. Therefore, in the current investigation, pachypodol, a potent antioxidant flavonoid, was used to cure PFOS-generated testicular dysfunctions in rats.

As evident, ROS are free radicals that arise from oxygen through orderly cellular metabolism (Staveness et al., 2016). Nitric oxide (NO), hydrogen peroxide (H2O2), hydroxyl radical (OH), and superoxide anion (O2–) are the central reactive oxygen and nitrogen species (Lü et al., 2010). OS occurs when there is instability between ROS concentration and the body's antioxidant defense system (Pisoschi et al., 2021). Antioxidant defense systems include CAT, SOD, GPx, and GSR that act as the major lines of the body's defense and protect biomolecules (lipids, protein, deoxyribose nucleic acid; DNA) from OS by decreasing the overproduction of ROS (Papas et al., 2019). SOD is a vital free radical scavenger enzyme that converts O2– into H2O2 (Bromfield, 2016), then CAT transforms H2O2 into H2O (Jonakova et al., 2010). GPx helps in the degradation of H2O2 by converting reduced glutathione (GSH) into glutathione disulfide (GSSG) (Schjenken and Robertson, 2014). On the other hand, GSH functions as an electron donor in these reactions. The concentration of GSH is retained by GSR, which is crucial for sperm production (Ali et al., 2020). Thus, a decline in the activities of antioxidant enzymes elevates the concentration of ROS, which attacks the PUFA in the sperm plasma membrane and triggers a cascade of chemical reactions, which is known as LP (Fois et al., 2018). In this study, TBARS as a marker of LP increased the membrane permeability. As confirmed by the outcomes of the current study, PFOS exposure decreased the activities of cellular enzymatic defense such as CAT, SOD, GPx, and GSR, while increasing the concentration of ROS and TBARS levels. However, this reduced activity of antioxidant enzymes in rat testicles was enhanced by the cotreatment of rats with pachypodol, probably due to its antioxidant property.

Secondly, PFOS-intoxication caused a decrease in viability, motility, epididymal sperm, and HOS coiled-tail sperm count in addition to higher levels of abnormality in the head, mid-piece, and tail of sperm. OS plays a significant role in testicular impairments (Ijaz et al., 2021b). The imbalance of the antioxidants/oxidants or ROS-prompts membrane damage due to the high level of PUFAs in sperm might be the reason behind the distorted integrity of sperm, as confirmed by the HOS test in the present study. Nevertheless, pachypodol administration successfully resettled all the spermatogenic damages due to its potent ROS scavenging activity.

Moreover, the successful regulation of the reproductive process depends upon the hormones working in the hypothalamic-pituitary-gonadal (HPG) axis (Acevedo-Rodriguez et al., 2018). In males, it affects the subsistence of testosterone generation and spermatogenesis, which is critically reliant on the two pituitary gonadotropins, LH and FSH (Sengupta et al., 2019). LH accounts for the stimulation of Leydig cells (LCs) to produce testosterone, whereas FSH sustains the proliferation of immature Sertoli cells (SCs) in synergy with testosterone (androgen) (Ramaswamy and Weinbauer, 2014. The generation of nutrients and molecules is required for spermatids' growth and the release of sperm (Oduwole et al., 2018). In the contemporary study, PFOS exposure lessened the gonadotropins and androgen levels, which may be due to a disruption of the normal physiological axis connecting the hypothalamus with the pituitary gland and the testes. However, pachypodol treatment potentially ameliorated PFOS-induced dysregulation of the hormonal assay.

Similarly, spermatogenesis is a crucial phase in the male reproductive system. During spermatogenesis, germ cells in the seminiferous tubules go through mitotic and meiotic division, forming haploid spermatids. These spermatids, later on, remodel and finally develop into mature spermatozoa (sperm) (Nishimura and L’Hernault, 2017). The germ cells manifest androgen receptors and thus are steadily react to the hormonal milieu enclosing them. Any alterations in the hormone levels could appear in damaged spermatogenesis (Griswold, 2016). Outcomes of the current research demonstrate that PFOS exposure caused severe histopathological alterations in the testis of the rats. In the current study, the decline in the hormonal levels after PFOS exposure is the probable reason behind the spermatogenic impairments, decreased seminiferous epithelial height, tubular diameter, and tunica albuginea thickness; besides escalated interstitial space and diameter of the tubular lumen. However, pachypodol treatment significantly alleviated the histopathological impairments provoked by PFOS. Pachypodol improved histopathological profile might be due to its antioxidant, androgenic, and anti-apoptotic potential.

5. Conclusion

In conclusion, exposure to PFOS prompted damages in semen, hormonal, and histopathological profiles in adult male Sprague-Dawley rats. Additionally, the activities of antioxidant enzymes, the concentration of ROS, and the TBARS level presented a state of imbalance, thereby impairing the structure and physiology of the entire male reproductive system. Nonetheless, pachypodol treatment remarkably mitigated PFOS-induced impairments in all the above-stated parameters due to its antioxidant androgenic potential. Depending on these in vivo findings, further researches on the remedial impacts of pachypodol, particularly on the reproductive system, are needed to entirely explore its health-promoting potential that forms the scientific foundation for supporting its consumption.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgement

The authors (SM and KAG) express their sincere appreciation to the Researchers Supporting Project number (RSP-2021/93), King Saud University, Riyadh, Saudi Arabia.

Footnotes

Peer review under responsibility of King Saud University.

Contributor Information

Asma Ashraf, Email: asmabinm@gmail.com.

S. Mahboob, Email: mushahid@ksu.edu.sa.

References

  1. Acevedo-Rodriguez A., Kauffman A.S., Cherrington B.D., Borges C.S., Roepke T.A., Laconi M. Emerging insights into hypothalamic-pituitary-gonadal axis regulation and interaction with stress signalling. J. Neuroendocrinol. 2018;30 doi: 10.1111/jne.12590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agarwal A., Sengupta P. Male Infertility. Springer; Cham: 2020. Oxidative stress and its association with male infertility; pp. 57–68. [Google Scholar]
  3. Alam M.N., Han X., Nan B., Liu L., Tian M., Shen H., Huang Q. Chronic low-level perfluorooctane sulfonate (PFOS) exposure promotes testicular steroidogenesis through enhanced histone acetylation. Environ. Pollut. 2021;284 doi: 10.1016/j.envpol.2021.117518. [DOI] [PubMed] [Google Scholar]
  4. Ali S.S., Ahsan H., Zia M.K., Siddiqui T., Khan F.H. Understanding oxidants and antioxidants: classical team with new players. J. Food. Biochem. 2020;44:13145. doi: 10.1111/jfbc.13145. [DOI] [PubMed] [Google Scholar]
  5. Bisht S., Faiq M., Tolahunase M., Dada R. Oxidative stress and male infertility. Nat. Rev. Urol. 2017;14:470–485. doi: 10.1038/nrurol.2017.69. [DOI] [PubMed] [Google Scholar]
  6. Bromfield J.J. A role for seminal plasma in modulating pregnancy outcomes in domestic species. Reproduction. 2016;152:R223–R232. doi: 10.1530/REP-16-0313. [DOI] [PubMed] [Google Scholar]
  7. Cao Z., Shao B., Xu F., Liu Y., Li Y., Zhu Y. Protective effect of selenium on aflatoxin B1-induced testicular toxicity in mice. Biol. Trace. Elem. Res. 2017;180:233–238. doi: 10.1007/s12011-017-0997-z. [DOI] [PubMed] [Google Scholar]
  8. Carlberg I., Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 1975;250:5475–5480. [PubMed] [Google Scholar]
  9. Chance B., Maehly A. [136] assay of catalases and peroxidases. Methods. Enzymol. 1955;2:764–775. doi: 10.1002/9780470110171.ch14. [DOI] [PubMed] [Google Scholar]
  10. Chen J., Miao Y., Gao Q., Cui Z., Xiong B. Exposure to perfluorooctane sulfonate in vitro perturbs the quality of porcine oocytes via induction of apoptosis. Environ. Pollut. 2021;284 doi: 10.1016/j.envpol.2021.117508. [DOI] [PubMed] [Google Scholar]
  11. Coperchini F., Awwad O., Rotondi M., Santini F., Imbriani M., Chiovato L. Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) J. Endocrinol. Invest. 2017;40:105–121. doi: 10.1007/s40618-016-0572-z. [DOI] [PubMed] [Google Scholar]
  12. Correa J.R., Zavos P.M. The hypoosmotic swelling test: its employment as an assay to evaluate the functional integrity of the frozen-thawed bovine sperm membrane. Theriogenology. 1994;42:351–360. doi: 10.1016/0093-691x(94)90280-1. [DOI] [PubMed] [Google Scholar]
  13. Di Nisio A., Sabovic I., Valente U., Tescari S., Rocca M.S., Guidolin D., Dall’Acqua S., Acquasaliente L., Pozzi N., Plebani M., Garolla A. Endocrine disruption of androgenic activity by perfluoroalkyl substances: clinical and experimental evidence. J. Clin. Endocrinol. Metab. 2019;104:1259–1271. doi: 10.1210/jc.2018-01855. [DOI] [PubMed] [Google Scholar]
  14. Fois A.G., Paliogiannis P., Sotgia S., Mangoni A.A., Zinellu E., Pirina P., Carru C., Zinellu A. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respir. Res. 2018;19:51. doi: 10.1186/s12931-018-0754-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gao Y., Chen H., Xiao X., Lui W.Y., Lee W.M., Mruk D.D., Cheng C.Y. Perfluorooctanesulfonate (PFOS)-induced Sertoli cell injury through a disruption of F-actin and microtubule organization is mediated by Akt1/2. Sci. Rep. 2017;7:1–14. doi: 10.1038/s41598-017-01016-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Griswold M.D. Spermatogenesis: the commitment to meiosis. Physiol. Rev. 2016;96:1–17. doi: 10.1152/physrev.00013.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hayashi I., Morishita Y., Imai K., Nakamura M., Nakachi K., Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat. Res. Genet. Toxicol Environ. Mutagen. 2007;631:55–61. doi: 10.1016/j.mrgentox.2007.04.006. [DOI] [PubMed] [Google Scholar]
  18. Ijaz M.U., Anwar H., Iqbal S., Ismail H., Ashraf A., Mustafa S., Samad A. Protective effect of myricetin on nonylphenol-induced testicular toxicity: biochemical, steroidogenic, hormonal, spermatogenic, and histological-based evidences. Environ. Sci. Pollut. Res. 2021;28:22742–22757. doi: 10.1007/s11356-020-12296-5. [DOI] [PubMed] [Google Scholar]
  19. Ijaz M.U., Tahir A., Samad A., Anwar H. Nobiletin ameliorates nonylphenol-induced testicular damage by improving biochemical, steroidogenic, hormonal, spermatogenic, apoptotic, and histological profile. Hum. Exp. Toxicol. 2021;40:403–416. doi: 10.1177/0960327120950007. [DOI] [PubMed] [Google Scholar]
  20. Ijaz M.U., Tahir A., Samad A., Ashraf A., Ameen M., Imran M., Yousaf S., Sarwar N. Casticin alleviates testicular and spermatological damage induced by cisplatin in rats. Pak. Vet. J. 2020;40:234–238. [Google Scholar]
  21. Iqbal M., Sharma S.D., Zadeh H.R., Hasan N., Abdulla M., Athar M. Gluthathione metabolizing enzymes and oxidative stress in ferric nitrioltriacetate mediated hepatic injury. Redox. Rep. 1996;2:385–391. doi: 10.1080/13510002.1996.11747079. [DOI] [PubMed] [Google Scholar]
  22. Jonakova V., Jonak J., Ticha M. Proteomics of male seminal plasma. Reprod. Genom. Domest. Anim. 2010:339–368. [Google Scholar]
  23. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian. J. Biochem. Biophys. 1984;21:130–132. [PubMed] [Google Scholar]
  24. Kenjale R., Shah R., Sathaye S. Effects of Chlorophytum borivilianum on sexual behaviour and sperm count in male rats. Phytother. Res.: Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Product Derivat. 2008;22:796–801. doi: 10.1002/ptr.2369. [DOI] [PubMed] [Google Scholar]
  25. Kim E.K., Kim J.H., Jeong S., Choi Y.W., Choi H.J., Kim C.Y., Kim Y.M. Pachypodol, a methoxyflavonoid isolated from Pogostemon cablin bentham exerts antioxidant and cytoprotective effects in HepG2 cells: possible role of ERK-dependent Nrf2 activation. Int. J. Mol. Sci. 2019;20:4082. doi: 10.3390/ijms20174082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Krithika S., Sadiq M., Ramanujam G.M., Maruthapillai A. Trimethoxy flavone, pachypodol containing pogostemon cablin leaf extract shows broad spectrum antimicrobial activity. Mater. Today: Proc. 2021 [Google Scholar]
  27. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium–deficient rat liver. Biochem. Biophys. Res. Commun. 1976;71:952–958. doi: 10.1016/0006-291x(76)90747-6. [DOI] [PubMed] [Google Scholar]
  28. Li C., Liu X., Liu Q., Li S., Li Y., Hu H., Shao J. Taurine. Springer; Dordrecht: 2017. Protection of taurine against PFOS-induced neurotoxicity in PC12 cells; pp. 907–916. [DOI] [PubMed] [Google Scholar]
  29. Li Y., Fletcher T., Mucs D., Scott K., Lindh C.H., Tallving P., Jakobsson K. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup. Environ. Med. 2018;75:46–51. doi: 10.1136/oemed-2017-104651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Liu J., Wang X., Yong H., Kan J., Jin C. Recent advances in flavonoid-grafted polysaccharides: Synthesis, structural characterization, bioactivities and potential applications. Int. J. Biol. Macromol. 2018;116:1011–1025. doi: 10.1016/j.ijbiomac.2018.05.149. [DOI] [PubMed] [Google Scholar]
  31. Lü J.M., Lin P.H., Yao Q., Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J. Cell. Mol. Med. 2010;14:840–860. doi: 10.1111/j.1582-4934.2009.00897.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nabavi S.M., Šamec D., Tomczyk M., Milella L., Russo D., Habtemariam S., Suntar I., Rastrelli L., Daglia M., Xiao J., Giampieri F. Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering. Biotechnol. Adv. 2020;38 doi: 10.1016/j.biotechadv.2018.11.005. [DOI] [PubMed] [Google Scholar]
  33. Negri E., Metruccio F., Guercio V., Tosti L., Benfenati E., Bonzi R., La Vecchia C., Moretto A. Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data. Crit. Rev. Toxicol. 2017;47:489–515. doi: 10.1080/10408444.2016.1271972. [DOI] [PubMed] [Google Scholar]
  34. Nishimura H., L’Hernault S.W. Spermatogenesis. Curr. Biol. 2017;27:R988–R994. doi: 10.1016/j.cub.2017.07.067. [DOI] [PubMed] [Google Scholar]
  35. Oduwole O.O., Peltoketo H., Huhtaniemi I.T. Role of follicle-stimulating hormone in spermatogenesis. Front. Endocrinol. 2018;9:763. doi: 10.3389/fendo.2018.00763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. OECD, 2018. Summary report on updating the OECD 2007 list of per- and polyfluoroalkyl substances 2018, May 4.
  37. Oseguera-López I., Pérez-Cerezales S., Ortiz-Sánchez P.B., Mondragon-Payne O., Sánchez-Sánchez R., Jiménez-Morales I., Fierro R., González-Márquez H. Perfluorooctane Sulfonate (PFOS) and Perfluorohexane Sulfonate (PFHxS) Alters Protein Phosphorylation, Increase ROS Levels and DNA Fragmentation during In Vitro Capacitation of Boar Spermatozoa. Animals. 2020;10:1934. doi: 10.3390/ani10101934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Papas M., Arroyo L., Bassols A., Catalán J., Bonilla-Correal S., Gacem S., Yeste M., Miró J. Activities of antioxidant seminal plasma enzymes (SOD, CAT, GPX and GSR) are higher in jackasses than in stallions and are correlated with sperm motility in jackasses. Theriogenology. 2019;140:180–187. doi: 10.1016/j.theriogenology.2019.08.032. [DOI] [PubMed] [Google Scholar]
  39. Pisoschi A.M., Pop A., Iordache F., Stanca L., Predoi G., Serban A.I. Oxidative stress mitigation by antioxidants-an overview on their chemistry and influences on health status. Eur. J. Med. Chem. 2021;209 doi: 10.1016/j.ejmech.2020.112891. [DOI] [PubMed] [Google Scholar]
  40. Poothong S., Papadopoulou E., Padilla-Sánchez J.A., Thomsen C., Haug L.S. Multiple pathways of human exposure to poly-and perfluoroalkyl substances (PFASs): from external exposure to human blood. Environ. Int. 2020;134 doi: 10.1016/j.envint.2019.105244. [DOI] [PubMed] [Google Scholar]
  41. Ramaswamy S., Weinbauer G.F. Endocrine control of spermatogenesis: Role of FSH and LH/testosterone. Spermatogenesis. 2014;4 doi: 10.1080/21565562.2014.996025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schjenken J.E., Robertson S.A. Seminal fluid and immune adaptation for pregnancy–comparative biology in mammalian species. Reprod. Domest. Anim. 2014;49:27–36. doi: 10.1111/rda.12383. [DOI] [PubMed] [Google Scholar]
  43. Sengupta P., Arafa M., Elbardisi H. Molecular Signaling in Spermatogenesis and Male Infertility. CRC Press; 2019. Hormonal regulation of spermatogenesis; pp. 41–49. [Google Scholar]
  44. Song X., Tang S., Zhu H., Chen Z., Zang Z., Zhang Y., Niu X., Wang X., Yin H., Zeng F., He C. Biomonitoring PFAAs in blood and semen samples: investigation of a potential link between PFAAs exposure and semen mobility in China. Environ. Int. 2018;113:50–54. doi: 10.1016/j.envint.2018.01.010. [DOI] [PubMed] [Google Scholar]
  45. Staveness D., Bosque I., Stephenson C.R. Free radical chemistry enabled by visible light-induced electron transfer. Acc. Chem. Res. 2016;49:2295–2306. doi: 10.1021/acs.accounts.6b00270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sunderland E.M., Hu X.C., Dassuncao C., Tokranov A.K., Wagner C.C., Allen J.G. A review of the pathways of human exposure to poly-and perfluoroalkyl substances (PFASs) and present understanding of health effects. J. Expo. Sci. Environ Epidemiol. 2019;29:131–147. doi: 10.1038/s41370-018-0094-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tescari C.F.S., Nisio A.D. Impact of perfluorochemicals on human health and reproduction : a male’s perspective. J. Endocrinol. Invest. 2017;41:639–645. doi: 10.1007/s40618-017-0790-z. [DOI] [PubMed] [Google Scholar]
  48. Toft G., Jönsson B.A.G., Lindh C.H., Giwercman A., Spano M., Heederik D., Lenters V., Vermeulen R., Rylander L., Pedersen H.S., Ludwicki J.K. Exposure to perfluorinated compounds and human semen quality in Arctic and European populations. Hum. Reprod. 2012;27:2532–2540. doi: 10.1093/humrep/des185. [DOI] [PubMed] [Google Scholar]
  49. Wan H.T., Mruk D.D., Wong C.K., Cheng C.Y. Perfluorooctanesulfonate (PFOS) perturbs male rat Sertoli cell blood-testis barrier function by affecting F-actin organization via p-FAK-Tyr407: an in vitro study. Endocrinology. 2014;155:249–262. doi: 10.1210/en.2013-1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Worley R.R., Fisher J. Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat. Toxicol. Appl. Pharmacol. 2015;289:428–441. doi: 10.1016/j.taap.2015.10.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Xu R., Shen Q., Li S., Li X., Li H., Lü Y., Lian Q.Q., Ge R.S. Effects of perfluoroalkyl substances on neurosteroid synthetic enzymes in the rat. Chem.-Biol. Interact. 2017;272:182–187. doi: 10.1016/j.cbi.2017.05.017. [DOI] [PubMed] [Google Scholar]
  52. Yilmaz S., Kaya E., Kisacam M.A. The effect on oxidative stress of aflatoxin and protective effect of lycopene on aflatoxin damage. Aflatoxin-Control, Analysis, Detection Health Risks. 2017;30:67–90. [Google Scholar]
  53. Yokoi K., Uthus E.O., Nielsen F.H. Nickel deficiency diminishes sperm quantity and movement in rats. Biol. Trace. Elem. Res. 2003;93:141–154. doi: 10.1385/BTER:93:1-3:141. [DOI] [PubMed] [Google Scholar]
  54. Zhang J., Zhu M., Zhang J. Pachypodol protects newborn rats from anaesthesia-induced apoptosis in the developing brain by regulating the JNK/ERK pathway. Int. J. Dev. Neurosci. 2021 doi: 10.1002/jdn.10140. [DOI] [PubMed] [Google Scholar]
  55. Zhang L., Duan X., Sun W., Sun H. Perfluorooctane sulfonate acute exposure stimulates insulin secretion via GPR40 pathway. Sci. Total Environ. 2020;726 doi: 10.1016/j.scitotenv.2020.138498. [DOI] [PubMed] [Google Scholar]

Articles from Saudi Journal of Biological Sciences are provided here courtesy of Elsevier

RESOURCES